Pre-order Enquiry
Request Free Sample
Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application
SKU ID : QYR-16598301 | Publishing Date : 23-Oct-2020 | No. of pages : 114
Detailed TOC of Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application
1 Market Overview of Vascular Endothelial Growth Factor (VEGF) Inhibitors1.1 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Overview
1.1.1 Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Scope
1.1.2 Market Status and Outlook
1.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Overview by Region 2015 VS 2020 VS 2026
1.3 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Region (2015-2026)
1.4 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Historic Market Size by Region (2015-2020)
1.5 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecast by Region (2021-2026)
1.6 Key Regions, Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2015-2026)
1.6.1 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2015-2026)
1.6.2 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2015-2026)
1.6.3 Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2015-2026)
1.6.4 Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2015-2026)
1.6.5 Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2015-2026)
2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Overview by Type
2.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type: 2015 VS 2020 VS 2026
2.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Historic Market Size by Type (2015-2020)
2.3 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecasted Market Size by Type (2021-2026)
2.4 VEGF-A Inhibitor
2.5 VEGF-B Inhibitor
2.6 VEGF-C Inhibitor
2.7 VEGF-D Inhibitor
3 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Overview by Application
3.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application: 2015 VS 2020 VS 2026
3.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Historic Market Size by Application (2015-2020)
3.3 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecasted Market Size by Application (2021-2026)
3.4 Oncology
3.5 Ophthalmology
4 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Competition Analysis by Players
4.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Players (2015-2020)
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors as of 2019)
4.3 Date of Key Manufacturers Enter into Vascular Endothelial Growth Factor (VEGF) Inhibitors Market
4.4 Global Top Players Vascular Endothelial Growth Factor (VEGF) Inhibitors Headquarters and Area Served
4.5 Key Players Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Solution and Service
4.6 Competitive Status
4.6.1 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Bayer AG
5.1.1 Bayer AG Profile
5.1.2 Bayer AG Main Business
5.1.3 Bayer AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Products, Services and Solutions
5.1.4 Bayer AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue (US$ Million) & (2015-2020)
5.1.5 Bayer AG Recent Developments
5.2 F. Hoffmann-La Roche Ltd.
5.2.1 F. Hoffmann-La Roche Ltd. Profile
5.2.2 F. Hoffmann-La Roche Ltd. Main Business
5.2.3 F. Hoffmann-La Roche Ltd. Vascular Endothelial Growth Factor (VEGF) Inhibitors Products, Services and Solutions
5.2.4 F. Hoffmann-La Roche Ltd. Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue (US$ Million) & (2015-2020)
5.2.5 F. Hoffmann-La Roche Ltd. Recent Developments
5.3 Novartis AG
5.5.1 Novartis AG Profile
5.3.2 Novartis AG Main Business
5.3.3 Novartis AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Products, Services and Solutions
5.3.4 Novartis AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue (US$ Million) & (2015-2020)
5.3.5 Regeneron Pharmaceuticals Inc. Recent Developments
5.4 Regeneron Pharmaceuticals Inc.
5.4.1 Regeneron Pharmaceuticals Inc. Profile
5.4.2 Regeneron Pharmaceuticals Inc. Main Business
5.4.3 Regeneron Pharmaceuticals Inc. Vascular Endothelial Growth Factor (VEGF) Inhibitors Products, Services and Solutions
5.4.4 Regeneron Pharmaceuticals Inc. Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue (US$ Million) & (2015-2020)
5.4.5 Regeneron Pharmaceuticals Inc. Recent Developments
5.5 Sanofi.
5.5.1 Sanofi. Profile
5.5.2 Sanofi. Main Business
5.5.3 Sanofi. Vascular Endothelial Growth Factor (VEGF) Inhibitors Products, Services and Solutions
5.5.4 Sanofi. Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue (US$ Million) & (2015-2020)
5.5.5 Sanofi. Recent Developments
...
6 North America
6.1 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Region
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Dynamics
11.1 Industry Trends
11.2 Market Drivers
11.3 Market Challenges
11.4 Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Figures, Tables and Charts Available in Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application
List of TablesTable 1. Global Market Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (US$ Million) Comparison by Region 2015 VS 2020 VS 2026
Table 2. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Region (2015-2020) (US$ Million)
Table 3. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Share by Region (2015-2020)
Table 4. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecasted Market Size by Region (2021-2026) (US$ Million)
Table 5. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecasted Market Size Share by Region (2021-2026)
Table 6. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (US$ Million) by Type: 2015 VS 2020 VS 2026
Table 7. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2015-2020) (US$ Million)
Table 8. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue Market Share by Type (2015-2020)
Table 9. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecasted Market Size by Type (2021-2026) (US$ Million)
Table 10. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue Market Share by Type (2021-2026)
Table 11. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (US$ Million) by Application: 2015 VS 2020 VS 2026
Table 12. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2015-2020) (US$ Million)
Table 13. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue Market Share by Application (2015-2020)
Table 14. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecasted Market Size by Application (2021-2026) (US$ Million)
Table 15. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue Market Share by Application (2021-2026)
Table 16. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue (US$ Million) by Players (2015-2020)
Table 17. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue Market Share by Players (2015-2020)
Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors as of 2019)
Table 19. Date of Key Manufacturers Enter into Vascular Endothelial Growth Factor (VEGF) Inhibitors Market
Table 20. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Top Players Headquarters and Area Served
Table 21. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Solution and Service
Table 22. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Bayer AG Basic Information List
Table 25. Bayer AG Description and Business Overview
Table 26. Bayer AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Products, Services and Solutions
Table 27. Revenue (Million US$) in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business of Bayer AG (2015-2020)
Table 28. Bayer AG Recent Developments
Table 29. F. Hoffmann-La Roche Ltd. Basic Information List
Table 30. F. Hoffmann-La Roche Ltd. Description and Business Overview
Table 31. F. Hoffmann-La Roche Ltd. Vascular Endothelial Growth Factor (VEGF) Inhibitors Products, Services and Solutions
Table 32. Revenue (Million US$) in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business of F. Hoffmann-La Roche Ltd. (2015-2020)
Table 33. F. Hoffmann-La Roche Ltd. Recent Developments
Table 34. Novartis AG Basic Information List
Table 35. Novartis AG Description and Business Overview
Table 36. Novartis AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Products, Services and Solutions
Table 37. Revenue (Million US$) in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business of Novartis AG (2015-2020)
Table 38. Novartis AG Recent Developments
Table 39. Regeneron Pharmaceuticals Inc. Basic Information List
Table 40. Regeneron Pharmaceuticals Inc. Description and Business Overview
Table 41. Regeneron Pharmaceuticals Inc. Vascular Endothelial Growth Factor (VEGF) Inhibitors Products, Services and Solutions
Table 42. Revenue (Million US$) in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business of Regeneron Pharmaceuticals Inc. (2015-2020)
Table 43. Regeneron Pharmaceuticals Inc. Recent Developments
Table 44. Sanofi. Basic Information List
Table 45. Sanofi. Description and Business Overview
Table 46. Sanofi. Vascular Endothelial Growth Factor (VEGF) Inhibitors Products, Services and Solutions
Table 47. Revenue (Million US$) in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business of Sanofi. (2015-2020)
Table 48. Sanofi. Recent Developments
Table 49. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2015-2020) & (US$ Million)
Table 50. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Share by Country (2015-2020)
Table 51. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2015-2020) & (US$ Million)
Table 52. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Share by Country (2015-2020)
Table 53. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Region (2015-2020) & (US$ Million)
Table 54. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Share by Region (2015-2020) (US$ Million)
Table 55. Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2015-2020) & (US$ Million)
Table 56. Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Share by Country (2015-2020) (US$ Million)
Table 57. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Players (2015-2020) (US$ Million)
Table 58. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Share by Players (2015-2020) (US$ Million)
Table 59. Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Trends
Table 60. Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Drivers
Table 61. Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Challenges
Table 62. Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Restriants
Table 63. Research Programs/Design for This Report
Table 64. Key Data Information from Secondary Sources
Table 65. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Year-over-Year 2015-2026 & (US$ Million)
Figure 2. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (US$ Million), 2015 VS 2020VS 2026
Figure 3. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Regions: 2020 VS 2026
Figure 4. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (US$ Million) Growth Rate (2015-2026)
Figure 5. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (US$ Million) and Growth Rate (2015-2026)
Figure 6. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (US$ Million) and Growth Rate (2015-2026)
Figure 7. Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (US$ Million) and Growth Rate (2015-2026)
Figure 8. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (US$ Million) and Growth Rate (2015-2026)
Figure 9. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Type in 2020 & 2026
Figure 10. VEGF-A Inhibitor Market Size (US$ Million) YoY Growth (2015-2026)
Figure 11. VEGF-B Inhibitor Market Size (US$ Million) YoY Growth (2015-2026)
Figure 12. VEGF-C Inhibitor Market Size (US$ Million) YoY Growth (2015-2026)
Figure 13. VEGF-D Inhibitor Market Size (US$ Million) YoY Growth (2015-2026)
Figure 14. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Share by Application in 2020 & 2026
Figure 15. Oncology Market Size (US$ Million) YoY Growth (2015-2026)
Figure 16. Ophthalmology Market Size (US$ Million) YoY Growth (2015-2026)
Figure 17. Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 18. Global Top 5 and Top 10 Players Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share in 2019
Figure 19. United States Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Canada Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Germany Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. France Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. U.K. Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Italy Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Russia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Nordic Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Rest of Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Japan Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. South Korea Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Southeast Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. India Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Australia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Rest of Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Mexico Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Brazil Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Rest of Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Turkey Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Saudi Arabia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. UAE Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Rest of Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Bottom-up and Top-down Approaches for This Report
Figure 43. Data Triangulation
Keyplayers in Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application
Bayer AGF. Hoffmann-La Roche Ltd.
Novartis AG
Regeneron Pharmaceuticals Inc.
Sanofi.
Request Sample
Request Discount
